In colorectal cancer liver metastasis, the emergence of CD4+FOXP3+ Tregs, coupled with elevated levels of α-smooth muscle Actin, HGF, and c-MET, suggests potential therapeutic targets for this metastatic variant of colorectal cancer (54). Here, MET is linked to colorectal cancer.